Yonghua Jing, PhD

Higher patient cost-sharing is associated with a lower likelihood of treatment augmentation in patients with depression who are treated with antidepressants.

When a clinical staging algorithm for treatment-resistant depression was applied to administrative claims data, higher scores predicted higher future medical costs.